Synektik (FRA:A2P) Other Current Liabilities: €9.4 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:A2P Synektik SA FRA:A2P
67 GF Score
Price €87.35
GF Value €53.43
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Synektik Other Current Liabilities?

Synektik FRA:A2P +0.34% 67 Other Current Liabilities is €9.4 Mil as of Mar. 2026. GuruFocus rates FRA:A2P with a GF Score™ of 67/100 and a GF Value™ of €53.43 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Synektik's other current liabilities for the quarter that ended in Mar. 2026 was €9.4 Mil.

Synektik's quarterly other current liabilities increased from Sep. 2025 (€9.4 Mil) to Dec. 2025 (€10.3 Mil) but then declined from Dec. 2025 (€10.3 Mil) to Mar. 2026 (€9.4 Mil).

Synektik's annual other current liabilities increased from Sep. 2023 (€3.1 Mil) to Sep. 2024 (€7.2 Mil) and increased from Sep. 2024 (€7.2 Mil) to Sep. 2025 (€9.4 Mil).

Synektik Other Current Liabilities Related Terms

Synektik Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Synektik's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Synektik Other Current Liabilities Chart

Synektik Annual Data
Trend Dec15 Dec16 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.79 1.96 3.12 7.24 9.40

Synektik Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.53 7.24 9.40 10.33 9.41
FRA:A2P
67GF Score
Synektik SA FRA:A2P
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Synektik Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of €9.4 Mil mean?
Synektik (FRA:A2P) has a Other Current Liabilities of €9.4 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Synektik.
Is Synektik's Other Current Liabilities too high?
Synektik's current Other Current Liabilities is €9.4 Mil. Overall, Synektik has a GF Score™ of 67/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Synektik's Other Current Liabilities compare to ABT and SYK?
Synektik's Other Current Liabilities of €9.4 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Medical Devices & Instruments company?
A good Other Current Liabilities depends on the Medical Devices & Instruments industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Synektik. Synektik's current Other Current Liabilities is €9.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synektik stock overvalued right now?
Based on GuruFocus' analysis, Synektik (FRA:A2P) is currently considered Significantly Overvalued. The stock's GF Value™ is €53.43, compared to a current price of €87.35 — trading 63.5% above its estimated fair value. The current Other Current Liabilities is €9.4 Mil. Synektik's overall GF Score™ is 67/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Synektik (FRA:A2P), the current Other Current Liabilities is €9.4 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Synektik (FRA:A2P) Overvalued in 2026?

Based on GuruFocus' analysis, Synektik stock appears to be overvalued. The current stock price of €87.35 is trading 63.5% above its estimated GF Value™ of €53.43. GuruFocus considers Synektik to be Significantly Overvalued.

Key valuation signals for FRA:A2P:

  • Other Current Liabilities: €9.4 Mil
  • GF Value™: €53.43 vs. price of €87.35 (63.5% above fair value)
  • GF Score™: 67/100 with 7 warning signs

No single metric tells the full story. See the FRA:A2P stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Synektik Business Description

Other Exchanges SNT:Poland
Address Aleja Wincentego Witosa 31, Warsaw, POL, 00-710
Synektik SA is a supplier of innovative products, services and IT solutions for diagnostic imaging and nuclear medicine. It sells medical devices and IT solutions used in radiology and operates research laboratory for diagnostic imaging systems and a service centre for medical equipment. Its operating segments include the sale of medical equipment used in radiology and nuclear medicine and IT solutions, Maintenance services for medical equipment as well as acceptance and specialist tests and Radiopharmaceutical production.
67GF Score

Get the complete analysis for FRA:A2P

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€87.35
Price
€53.43
GF Value